1 / 27

MALARIA ASSOCIATED RENAL FAILURE

MALARIA ASSOCIATED RENAL FAILURE. Common in the tropics Plasmodium falciparum Renal tubules Acute intravascular hemolysis Heavy parasitic infection. INTRAVASCULAR HEMOLYSIS. Malarial infection Antimalarial drugs G-6-P-D Deficiency Quinine, Phosphates, Pyrimethamine. BLACKWATER FEVER.

Faraday
Download Presentation

MALARIA ASSOCIATED RENAL FAILURE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MALARIA ASSOCIATED RENAL FAILURE Common in the tropics Plasmodium falciparum Renal tubules Acute intravascular hemolysis Heavy parasitic infection

  2. INTRAVASCULAR HEMOLYSIS • Malarial infection • Antimalarial drugs • G-6-P-D Deficiency • Quinine, Phosphates, Pyrimethamine

  3. BLACKWATER FEVER • Hemoglobinemia • Hemoglobinuria • Exclude drug causation • Scanty parasitemia • Re-infection in non-immune immigrants • Acute renal failure • Uncommon in Kenya

  4. RENAL HISTOPATHOLOGY OF BLACKWATER FEVER • Tubular Atrophy • Interstitial Lymphocyte infiltration • Focal fibrosis • Iron pigments in fibroblasts and tubules • Heme casts in tubular lumen

  5. CAUSES OF HEMOLYSIS IN FALCIPARUM MALARIA • Impairment in physiologic deformity • Increased mechanical fragility • Interference with RBC ATP • Interference with Na-K RBC ATP • Altered charges on RBC surface • Immunologic reactions

  6. MALARIA ASSOCIATED ACUTE RENAL FAILURE • Common cause of MARF • Heavy parasitemia • 1% to 4% develop ARF • 60% in Malignant malaria • Usually oliguric • Catabolic State • Cholestatic Jaundice • Rarely hepatocellular • Lasts a few days to several weeks

  7. MALARIA ASSOCIATED ACUTE RENAL FAILURE • Occurs 4 - 7 days from onset of fever • Early onset hyperkalemia • Hyperuricemia common • High urinary uric acid-creatinine ratio • Oliguria lasts a few days to several weeks

  8. HISTOPATHOLOGY OF MARF • Distal tubules, Necrosis, Degeneration • Proximal tubules • Cloudy swelling and Vacuolisation • Hemoglobin in lumen • Hemosiderin in Lumen • Oedematous interstitium • Tubular degeneration • Regeneration of epithelial cells • Dilatation of tubules • Features of acute tubular necrosis

  9. GLOMERULONEPHRITIS IN FALCIPARUM MALARIA • Manifestations include: • Mild proteinuria • Hematuria • Casts • Non-progressive,and reversible • ARF and Hypertension rare • Resolves in 4 – 6 weeks after antimalarials • Nephrotic syndrome is rare

  10. HISTOPATHOLOGY OF GLOMERULONEPHRITIS • Mild mononuclear cell infiltration • Prominent mesangial proliferation • Increased mesangial matrix • Normal glomerular capillaries • Immune complex mediated

  11. IMMUNOFLUORESCENCE OF GLOMERULAR LESIONS • Fine granular deposits of IgM and C3 • Capillary walls • Mesangium • Malarial antigens • Glomerular endothelium • Medullary capillaries

  12. ELECTRON MICROSCOPY OF GLOMERULONEPHRITIS • Electron dense deposits • Granular, Fibrillar, and Amorphous material • Situated in • Subendothelial, • Mesangial, • Paramesangial regions

  13. PATHOGENESIS OF MARF • Hypovolemia • Release of Kinins, Kallikreins, Histamine • Increased capillary permeability • Insensible fluid loss • Renin Angiotensin System stimulation • Increased catecholamine secretion • Hyperviscosity • Decreased RBC deformability • Elevated fibrinogen • Causes renal ischemia and MARF

  14. PATHOGENESIS OF MARF • INTRAVASCULAR COAGULATION • Fibrin degradation products • Prolonged pro-thrombin time • Thrombocytopenia • Decreased platelet life span • Platelet agglutination • Splenic pooling • Alteration in coagulation factors • Low grade regional intra-vascular coagulation • Stasis and Inflammation • Hemolysis and MARF

  15. PATHOGENESIS OF MARF • Fever • Cholestatic Jaundice • Obstructive Jaundice and ARF • Tubulotoxicity of Bile acids • Severe oliguria in association with Jaundice • Rhabdomyolysis. Rare • Myoadenyl deaminase deficiency MAD

  16. CYTOKINES IN MARF • Serum soluble CD14 • Marker of inflammatory response • Elevated in complicated Malaria • TNFalfa. • Associated with tissue damage • Stimulates expression of adhesion molecules • ELAM 1 and ICAM-1 • Facilitates thrombospondin secretion • IL-1, IL-6, IL-8 • Acute phase reactions • Expression of adhesion molecules • Release of vasoactive mediators • Plasma leakage from intravascular compartments

  17. CYTOKINES IN MARF • GPI. Glycosilphosphatidylinositol • Elevated in MARF • Glycolipid substances • Acts like an endotoxin • Can induce TNF and IL-1 • Cause hypoglycemia and pyrexia

  18. HUMORAL FACTORS IN MARF • Elevated catecholamines • Increased plasma renin activity • SIADHS • Inflammatory mediators • Kinins, Prosaglandins, • Histamine, Serotinin • Nitric Oxide, Endothelin, • Complement, Superoxidase

  19. ELECTROLYTE IMBALANCEIN MARF • Hyponatremia • 67% in heavy parasitemia • Dilutional • Water retention in renal failure • Resetting of osmoreceptors • SIADH due to fever • Delayed response to water load • Caution with IV fluids • Pulmonary edema a hazard

  20. ELECTROLYTE IMBALANCEIN MARF • Hypernatremia. Rare • Pure water depletion • Cerebral edema • Blunted thirst • Inadequate provision of water • Hypokalemia in uncomplicated malaria • Hyperkalemia • Hypocalcemia with severe infection • Hypophosphatemia wih severe infection

  21. TREATMENT OF MARF • Antimalarial therapy essential • Quinine. • Normal doses in MARF for first 24 to 48 hours • Thereafter reduce dose to 10 mg/kg 12 hourly • Or 24 hourly for 7 • Artemesin derivatives. Potent • Inhibit adherence properties • Reduce parasite count remarkably • Exchange transfusion

  22. TREATMENT OF MARF • Dialysis in hypercatabolic states • Hemodialysis or Hemofiltraion • Peritoneal dialysis less preferable • Impaired peritoneal microcirculation • Parasitised erythocytes • Vasoconstriction • Reduced solute transport • Improved efficiency as parasitemia declines • Continuous PD beneficial

  23. MULTIORGAN FAILURE IN MARF • Cerebral malaria • Hemodynamic shock • Respiratory distress • MARF • Hematological disorders • Digestive disorders • Often fatal

  24. MARF AT KNH • Were et al • 47 Patients with ARF • 21 (45%) with medical causes • 9 (19%) developed MARF • Overall mortality 40.4% • MARF mortality 33.3% • Cholestatic Jaundice in 4 patients • All patients with MARF were oliguric

  25. MARF AT KNH • Onset phase 2.9 days • Oliguria lasted 9.8 days • 5 patients not dialysed. 2 died • 4 patients had PD. 1 died • Mean duration of PD 11 days • Continuous PD. 8 cycles daily • All had heavy parasitemia. No BWF

  26. MARF IN VIETNAM (TANG ET AL) • 64 (MARF) vs 66 (Severe Malaria only) • Clinically and biochemically, ATN • Associated cholestatic jaundice, & liver dys • Fatality associated with • Anuria, Short duration of illness • Hyperparasitemia, Multisystem involvement • Recovery unrelated to parasitemia

  27. MARF IN VIETNAM (TANG ET AL) • Recovery unrelated to hemoglobinuria • Oliguria 4 days (0-19) • Normal biochemistry 17 days (11-23) • Treated by PD • Mortality decreased from 75% to 26% • Good condition initially • Complications develop rapidly • Treat as ATN with circulatory shock • Early diagnosis and dialysis mandatory

More Related